Inventor · disambiguated record
James Onuffer
Also filed as: ONUFFER JAMES · ONUFFER JAMES JOSEPH · ONUFFER JR JAMES JOSEPH
15 granted patents·13 pending applications·164 citations·filing 2003–2025
93Inventor score
Top patents by PatentIndex Score
28 records- 0198US9587020B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2016·Granted Mar 7, 2017·68 cites·26 claims
- 0297US9821012B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Nov 21, 2017·27 cites·27 claims
- 0396US10105391B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Oct 23, 2018·18 cites·20 claims
- 0494US10888581B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Jan 12, 2021·5 cites·29 claims
- 0593US11325948B2Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPLEXUMA BIOTECH CORP·Filed 2020·Granted May 10, 2022·6 cites·27 claims
- 0692US12258574B2Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2023·Granted Mar 25, 2025·1 cites·26 claims
- 0792US10596274B2Methods and compositions for transducing lymphocytes and regulated expansion thereofEXUMA BIOTECH CORP·Filed 2017·Granted Mar 24, 2020·10 cites·24 claims
- 0892US2025136659A1Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0990US10632152B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Apr 28, 2020·3 cites·36 claims
- 1088US11111505B2Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2017·Granted Sep 7, 2021·3 cites·21 claims
- 1187US12325728B2Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of CD79A and CD79BEXUMA BIOTECH CORP·Filed 2022·Granted Jun 10, 2025·1 cites·26 claims
- 1285US12161672B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2022·Granted Dec 10, 2024·0 cites·18 claims
- 1382US7220856B2Substituted quinoline CCR5 receptor antagonistsSCHERING AG·Filed 2003·Granted May 22, 2007·22 cites·8 claims
- 1480US2023257776A1Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2023·Application pending·0 cites
- 1577US12371466B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2020·Granted Jul 29, 2025·0 cites·13 claims
- 1677US2025236889A1Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2025·Application pending·0 cites
- 1776US2025026840A1Chimeric antigen receptors against axl or ror2 and methods of use thereofEXUMA BIOTECH CORP·Filed 2024·Application pending·0 cites
- 1874US11478510B2Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2020·Granted Oct 25, 2022·0 cites·20 claims
- 1973US2021403952A1Methods and compositions for transducing lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2021·Application pending·0 cites
- 2065US2025263750A1Deterministic mechanoporation devices, systems and methodsBASILARD BIOTECH INC·Filed 2024·Application pending·0 cites
- 2165US2015368342A1Chimeric antigen receptor and methods of use thereofUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 2262US2023392139A1Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2023·Application pending·0 cites
- 2357US12187801B2Chimeric antigen receptors against AXL or ROR2 and methods of use thereofEXUMA BIOTECH CORP·Filed 2018·Granted Jan 7, 2025·0 cites·22 claims
- 2454US2023072955A1Chimeric antigen receptors to her2 and methods of use thereofEXUMA BIOTECH CORP·Filed 2021·Application pending·0 cites
- 2550US2022340927A1Methods and compositions for the modification and delivery of lymphocytesEXUMA BIOTECH CORP·Filed 2020·Application pending·0 cites
- 2650US2021317408A1Methods and compositions for genetically modifying lymphocytes in blood or in enriched pbmcsEXUMA BIOTECH CORP·Filed 2019·Application pending·0 cites
- 2745US2019367876A1Methods of transducing and expanding immune cells and uses thereofF1 ONCOLOGY INC·Filed 2018·Application pending·0 cites
- 2845US2020397821A1Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereofEXUMA BIOTECH CORP·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Onuffer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →